N/A
N=7
Vagal Nerve Stimulation and Glucose Metabolism
Type 2 Diabetes · Obesity · Gastric Emptying
Bottom Line
View on ClinicalTrials.gov: NCT01117311 ↗Enrolled (actual)
7
Serious AEs
0.0%
Results posted
Jan 2014
Primary outcome: Primary: Disposition Index — 703; 532 10^-14dl/kg/min^2 per pmol/l
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- VNB on (Device); VNB off (Device)
- Age
- Adult, Older Adult · 35+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Jun 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Disposition Index |
703; 532 | — |
| SECONDARY Gastric Emptying Half-time |
167; 160 | — |
Summary
The overall aim of this application is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism. The study proposed will examine the effect of vagal nerve stimulation on insulin secretion and action.
Eligibility Criteria
Previous Implantation of a Vagal Nerve Stimulator for obesity as part of a prior study examining the effect of vagal nerve stimulator on obesity
Data sourced from ClinicalTrials.gov (NCT01117311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.